Clinical trial Recruiting at 7 sites Interventional Ages 22 and up Women only

Adjustable Continence Therapy for treating female stress urinary incontinence

Official title: A Clinical Investigation of the Adjustable Continence Therapy (ACT) for Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency

Run by Uromedica · NCT04248283 · Data updated 2026-11-12

This study is testing a new treatment called Adjustable Continence Therapy to see if it can help women with stress urinary incontinence who haven't had success with other treatments.

Quick facts

Study typeInterventional
Ages22 Years and up
SexWomen only
Enrollment167 (estimated)
SponsorUromedica
Industry-sponsored
Drugs / interventionsradiation
Locations8 sites (Denver, Colorado and 7 other locations)
StatusRecruiting
StartedJanuary 26, 2021
Main results expectedMay 31, 2027
Study endsMay 31, 2032
Registry record updatedOctober 6, 2026
Trial IDNCT04248283 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women aged 22 and older who have been diagnosed with stress urinary incontinence and have not found relief from previous treatments.

Probably not a fit

Patients who are pregnant, have uncontrolled diabetes, or are undergoing radiation therapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the safety and effectiveness of Adjustable Continence Therapy (ACT) in women diagnosed with stress urinary incontinence due to primary Intrinsic Sphincter Deficiency. It is a prospective, single-arm, non-randomized, multicenter case-series trial that will assess the clinical improvement in patients who have not responded to previous treatments. Participants will undergo the ACT procedure and will be monitored for outcomes related to urinary incontinence. The study seeks to provide valuable data on the therapeutic benefits of this innovative approach.

Why it matters

Potential benefit: If successful, this therapy could significantly improve the quality of life for women suffering from stress urinary incontinence.

How similar studies have gone: Other studies have shown promising results with similar therapeutic approaches, indicating potential for success with this method.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Female at least 22 years old
2. Diagnosed with stress urinary incontinence with primary Intrinsic Sphincter Deficiency
3. Provocative pad weight of greater than 11.0 grams
4. Candidate for surgical intervention
5. Negative urinalysis
6. Normal cystourethroscopy
7. Failed at least 6 months of previous treatment(s) for stress urinary incontinence (e.g., exercise regimen, electrical stimulation, surgical procedures, etc). Note: patients may have failed prior anti-incontinence procedures for SUI (e.g., suspension, sling, or urethral bulking agent)
8. Willing and able to sign informed consent and comply with trial follow-up requirements

Exclusion Criteria:

1. Pregnant or lactating
2. Life expectancy of less than 5 years
3. Has uncontrolled diabetes as evidenced by HbA1c over 6.5% and fasting plasma glucose over 130 mg/dL
4. Has auto-immune disease
5. Undergoing radiation therapy
6. Active urinary tract infection
7. Detrusor instability refractory to medication
8. Reduced bladder compliance as defined by a cystometrogram
9. Significant residual volume (greater than 100 ml) after voiding in which detrusor contraction is weak, when the bladder volume is greater than or equal to 250 ml
10. Has, had, or is suspected of having bladder cancer
11. History of bladder stones
12. Urethral stricture evidenced during cystourethroscopy
13. Has a neurogenic bladder that is atonic or has detrusor sphincter dyssynergia
14. Has a diathesis, hemophilia, or a bleeding disorder
15. Has a rectocele, cystocele, urethrocele, enterocele, or pelvic prolapse of grade 3 or higher
16. Had prior pelvic radiotherapy
17. Had a prior artificial urinary sphincter implanted
18. Has a neurogenic condition known to affect bladder/sphincter function

Where it's running

  • University of Colorado
    Denver, Colorado, United States
    Recruiting
  • Idaho Urologic Institute, PA
    Meridian, Idaho, United States
    Recruiting
  • CHI Health Research Center
    Omaha, Nebraska, United States
    Recruiting
  • Penn State University
    Hershey, Pennsylvania, United States
    Recruiting
  • Hôpital de la Conception - Marseille
    Marseille, France
    Recruiting
  • CHU de Nantes
    Nantes, France
    Recruiting
Show 2 more locations
  • Pitié Salpêtrière University Hospital Paris
    Paris, France
    Recruiting
  • Saint Lukes Health System
    Independence, Missouri, United States
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.